Nicholas Sotereanos, MD
Orthopaedic Surgery · Pittsburgh, PANPI 1003817107
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $76,125 of the $81,000 with a category attached, or 94.0%. 12 manufacturers reported payments, led by Kyocera Medical Technologies, Inc. at 55.6% of the total. Reporting peaked in 2019 at $32,521 and has fallen 87.6% since, to $4,025 in 2025. Among orthopaedic surgery clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 63 payments — averaging $1285.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kyocera Medical Technologies, Inc.$45K
- Renovis Surgical Technologies, Inc.$31K
- Stryker$3K
- Medtronic$520
- Zimmer Biomet$340
- Innovation Technologies Inc$240
- plus $677 from 6 others
What the payments were for
- Royalty or licence$76,12594%
- Travel & lodging$7501%
- Food & beverage$4,1265%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kyocera Medical Technologies, Inc. | 6 | $45,012 |
| Renovis Surgical Technologies, Inc. | 1 | $31,113 |
| Stryker | 25 | $3,099 |
| Medtronic(2 entities) | 11 | $520 |
| Zimmer Biomet | 5 | $340 |
| Innovation Technologies Inc | 3 | $240 |
| Johnson & Johnson | 3 | $225 |
| Pacira Pharmaceuticals Incorporated | 3 | $143 |
| Smith+Nephew | 2 | $125 |
| Next Science LLC | 1 | $114 |
| Medical Device Business Services, Inc. | 2 | $43 |
| Bioventus LLC | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$2,306
- AQUAMANTYS$226
- INSIGNIA$151
- SurgX$114
- Xperience$114
- Irrisept$110
- Iovera$110
- mymobility Platform$104
- Avenir$100
How this compares
$81,000 in reported general payments places this provider in the 90th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 23 | $758 |
| Celecoxib | 21 | $340 |
| Methylprednisolone | 43 | $315 |
| Amoxicillin | 140 | $270 |
| Clindamycin Hcl | 24 | $120 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Pittsburgh
- Edward WestrickPittsburgh$938K
- Timothy SauberPittsburgh$373K
- Eric YakishPittsburgh$278K
- Gary SchmidtPittsburgh$256K
- Ivan TarkinPittsburgh$243K
- Anthony DigioiaPittsburgh$217K
- Kenneth UrishPittsburgh$207K
- William HozackBensalem$10.6M
- Jess LonnerBryn Mawr$7.8M
- Gerald WilliamsBryn Mawr$6.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.